Skip to main content

Tropicamide

Generic: Tropicamide

Verified·Apr 23, 2026
Manufacturer
Alcon
NDC
85766-040
RxCUI
314238
Route
OPHTHALMIC
ICD-10 indication
Z01.00

Affordability Check

How much will you actually pay for Tropicamide?

In 30 seconds, see every legitimate way to afford Tropicamide — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Tropicamide

What is this medication?

Tropicamide is an ophthalmic medication used primarily to dilate the pupil, a process known as mydriasis. It belongs to a class of drugs called anticholinergics. By blocking certain receptors in the eye muscles, it allows the pupil to open wide and prevents it from responding to light. This effect is essential for eye doctors to clearly examine the internal structures of the eye, such as the retina, optic nerve, and lens during a comprehensive eye examination.

In addition to dilating the pupil, this medication is used to temporarily paralyze the eye muscles that control focusing, which is a state called cycloplegia. This is particularly helpful when an eye care professional needs to determine an accurate refractive error for glasses or during certain types of eye surgery. The effects of the drops generally begin within twenty to forty minutes and may last for several hours. Patients are usually advised to wear sunglasses and avoid tasks requiring clear vision, like driving, until their pupils return to their normal size.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Tropicamide. Official source: DailyMed (NLM) · Label effective Feb 6, 2026

Indications and usage
INDICATIONS AND USAGE For mydriasis and cycloplegia for diagnostic procedures.
Dosage and administration
DOSAGE AND ADMINISTRATION For refraction, instill one or two drops of 1% solution in the eye(s), repeated in five minutes. If patient is not seen within 20 to 30 minutes, an additional drop may be instilled to prolong mydriatic effect. Individuals with heavily pigmented irides may require higher strength or more doses. Mydriasis will reverse spontaneously with time, typically in 4 to 8 hours. However, in some cases, complete recovery may take up to 24 hours.
Contraindications
CONTRAINDICATIONS Contraindicated in persons showing hypersensitivity to any component of this preparation.
Warnings
WARNINGS FOR TOPICAL OPHTHALMIC USE ONLY. NOT FOR INJECTION. This preparation may cause CNS disturbances which may be dangerous in pediatric patients. The possibility of psychotic reactions and behavioral disturbances due to hypersensitivity to anticholinergic drugs should be considered. Mydriatics may produce a transient elevation of intraocular pressure. Remove contact lenses before using.
Drug interactions
Drug Interactions Tropicamide may interfere with the antihypertensive action of carbachol, pilocarpine, or ophthalmic cholinesterase inhibitors.
Adverse reactions
ADVERSE REACTIONS Ocular: Transient stinging, blurred vision, photophobia and superficial punctuate keratitis have been reported with the use of tropicamide. Increased intraocular pressure has been reported following the use of mydriatics. Non-Ocular: Dryness of the mouth, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, central nervous system disturbances and muscle rigidity have been reported with the use of tropicamide. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse in children have been reported with the use of anticholinergic drugs.
Use in pregnancy
Pregnancy Animal reproduction studies have not been conducted with tropicamide. It is also not known whether tropicamide can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Tropicamide should be given to a pregnant woman only if clearly needed.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.